220
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Comparison of C-reactive protein levels in pregnancies with retained and removed intrauterine device

, , , , &
Pages 1152-1154 | Received 01 Oct 2010, Accepted 21 Oct 2010, Published online: 13 Jan 2011

References

  • Thonneau P, Goulard H, Goyaux N. Risk factors for intrauterine device failure: a review. Contraception 2001;64:33–37.
  • Ministry of Health and Hacettepe University Institute of Population Studies. 2003 Turkey Demographic and Health Survey TDHS. http://www.hips.hacettepe.edu.tr
  • de Araujo FF, Barbieri M, Guazzelli CA, Lindsey PC. The T 380A intrauterine device: a retrospective 5-year evaluation. Contraception 2008;78:474–478.
  • Reinprayoon D. Intrauterine contraception. Curr Opin Obstet Gynecol 1992;4:527–530.
  • Rivera R, Chi IC, Farr G. The intrauterine device in the present and future. Curr Opin Obstet Gynecol 1993;5:829–832.
  • Speroff L, Darney PD. Intrauterine contraception (The IUD). In: A clinical guide for contraception. 2nd ed. Baltimore, MD: Williams & Wilkins. 1996.
  • Second Report on Intrauterine Contraceptive Devices, Food and Drug Administration, 1978; Population Reports, Series B, No. 3, May 1979, the Johns Hopkins University.
  • Cook NR, Buring JE, Ridker PM. The effect of including C-reactive protein in cardiovascular risk prediction models for women. Ann Intern Med 2006;145:21–29.
  • Cermak J, Key NS, Bach RR, Balla J, Jacob HS, Vercellotti GM. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 1993;82:513–520.
  • Mortensen RF. C-reactive protein, inflammation, and innate immunity. Immunol Res 2001;24:163–176.
  • Alvior GT Jr. Pregnancy outcome with removal of intrauterine device. Obstet Gynecol 1973;41:894–896.
  • Foreman H, Stadel BV, Schlesselman S. Intrauterine device usage and fetal loss. Obstet Gynecol 1981;58:669–677.
  • Skjeldestad FE, Hammervold R, Peterson DR. Outcomes of pregnancy with an IUD in situ – a population based case-control study. Adv Contracept 1988;4:265–270.
  • Tatum HJ, Schmidt FH, Jain AK. Management and outcome of pregnancies associated with the Copper T intrauterine contraceptive device. Am J Obstet Gynecol 1976;126:869–879.
  • Gómez R, Romero R, Nien JK, Medina L, Carstens M, Kim YM, Chaiworapongsa T, Espinoza J, González R. Idiopathic vaginal bleeding during pregnancy as the only clinical manifestation of intrauterine infection. J Matern Fetal Neonatal Med 2005;18:31–37.
  • Kim SK, Romero R, Kusanovic JP, Erez O, Vaisbuch E, Mazaki-Tovi S, Gotsch F, Mittal P, Chaiworapongsa T, Pacora P, Oggé G, Gomez R, Yoon BH, Yeo L, Lamont RF, Hassan SS. The prognosis of pregnancy conceived despite the presence of an intrauterine device (IUD). J Perinat Med 2010;38:45–53.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.